Microneedles (MNs) have been used to deliver drugs for over two decades. These platforms
have been proven to increase transdermal drug delivery efficiency dramatically by …

With the changing disease spectrum, atherosclerosis has become increasingly prevalent
worldwide and the associated diseases have emerged as the leading cause of death. Due …

Drug‐coated balloons (DCB) intervention is an important approach for the treatment of
atherosclerosis (AS). However, this therapeutic approach has the drawbacks of poor drug …

Drug-eluting balloon (DEB) angioplasty has emerged as an effective treatment for
cardiovascular and cerebrovascular diseases. However, distal embolism and late lumen …

Transdermal drug delivery (TDD) was initially limited to fewer therapeutic agents due to the
requirements of suitable physicochemical and biological properties for passage across the …

The applications of microneedles (MNs) are becoming popular with the promise of efficient
and advanced drug delivery. MNs were developed to overcome the limitations of …

High rates of restenosis and neointimal formation have driven increasing interest in the
application of drug eluting balloons (DEB) as counteractive measures for intraluminal drug …

Abstract Drug-Coated Balloons have shown promising results as a minimally invasive
approach to treat stenotic arteries, but recent animal studies have revealed limited, non …

Drug‐coated balloon (DCB) percutaneous interventional therapy allows for durable
reopening of the narrowed lumen via physical tissue expansion and local anti‐restenosis …

ABSTRACT Introduction Microneedles (MNs) have undergone great advances in
transdermal drug delivery, and commercialized MN applications are currently available in …